,TARGET.USI,TARGET.ID,Gender,Race,Ethnicity,Age.at.Diagnosis.in.Days,First.Event,Event.Free.Survival.Time.in.Days,Vital.Status,Overall.Survival.Time.in.Days,Year.of.Diagnosis,Year.of.Last.Follow.Up,STAGE,MYCN,Ploidy,Ploidy.Value,Histology,MKI,Diagnostic.Category,RISK,Site,nti_surv_overall,nti_event_overall_num,nti_surv_progrfree,nti_event_progrfree_num
TARGET-30-PANZRV-01A,TARGET-30-PANZRV,TARGET-30-PANZRV-01A,Male,White,Not Hispanic or Latino,72,Censored,3434,Alive,3434,2005,2015,4s,single_copy,Hyperdiploid (DI>1),2.5,Favorable,Intermediate,Neuroblastoma,Low,Primary tumor,3434,0,3434,0
TARGET-30-PAPICY-01A,TARGET-30-PAPICY,TARGET-30-PAPICY-01A,Female,White,Not Hispanic or Latino,58,Censored,205,Alive,205,2006,2006,4s,single_copy,Hyperdiploid (DI>1),1.31,Favorable,Intermediate,Neuroblastoma,Low,Primary tumor,205,0,205,0
TARGET-30-PAPTDH-01A,TARGET-30-PAPTDH,TARGET-30-PAPTDH-01A,Female,White,Not Hispanic or Latino,11,Second Malignant Neoplasm,193,Alive,3264,2006,2015,4s,single_copy,Hyperdiploid (DI>1),1.1,Favorable,Low,Neuroblastoma,Low,Primary tumor,3264,0,193,1
TARGET-30-PARFRE-01A,TARGET-30-PARFRE,TARGET-30-PARFRE-01A,Female,Unknown,Unknown,60,Censored,2451,Alive,2451,2007,2014,4s,single_copy,Hyperdiploid (DI>1),1.46,Favorable,Unknown,Neuroblastoma,Low,Primary tumor,2451,0,2451,0
TARGET-30-PARJVP-01A,TARGET-30-PARJVP,TARGET-30-PARJVP-01A,Male,Unknown,Not Hispanic or Latino,56,Censored,2064,Alive,2064,2007,2013,4s,single_copy,Hyperdiploid (DI>1),2.04,Favorable,Unknown,Neuroblastoma,Low,Primary tumor,2064,0,2064,0
TARGET-30-PARNNC-01A,TARGET-30-PARNNC,TARGET-30-PARNNC-01A,Female,White,Not Hispanic or Latino,41,Relapse,735,Alive,2611,2007,2014,4s,single_copy,Hyperdiploid (DI>1),1.31,Favorable,Low,Neuroblastoma,Low,Primary tumor,2611,0,735,1
TARGET-30-PARZHA-01A,TARGET-30-PARZHA,TARGET-30-PARZHA-01A,Male,Unknown,Unknown,3,Censored,2489,Alive,2489,2008,2015,4s,single_copy,Hyperdiploid (DI>1),1.21,Favorable,Low,Neuroblastoma,Low,Primary tumor,2489,0,2489,0
TARGET-30-PASFIC-01A,TARGET-30-PASFIC,TARGET-30-PASFIC-01A,Male,White,Not Hispanic or Latino,51,Censored,2152,Alive,2152,2008,2014,4s,single_copy,Hyperdiploid (DI>1),1.67,Favorable,Low,Neuroblastoma,Low,Primary tumor,2152,0,2152,0
TARGET-30-PASMDM-01A,TARGET-30-PASMDM,TARGET-30-PASMDM-01A,Male,White,Not Hispanic or Latino,25,Censored,1324,Alive,1324,2009,2012,4s,single_copy,Hyperdiploid (DI>1),2.27,Favorable,Low,Neuroblastoma,Low,Primary tumor,1324,0,1324,0
TARGET-30-PASNML-01A,TARGET-30-PASNML,TARGET-30-PASNML-01A,Male,Not Reported,Not Hispanic or Latino,8,Censored,2185,Alive,2185,2009,2015,4s,single_copy,Hyperdiploid (DI>1),1.28,Favorable,Intermediate,Neuroblastoma,Low,Primary tumor,2185,0,2185,0
TARGET-30-PATAYJ-01A,TARGET-30-PATAYJ,TARGET-30-PATAYJ-01A,Male,White,Not Hispanic or Latino,52,Censored,1744,Alive,1744,2009,2014,4s,single_copy,Hyperdiploid (DI>1),1.62,Favorable,Low,Neuroblastoma,Low,Primary tumor,1744,0,1744,0
TARGET-30-PATGJU-01A,TARGET-30-PATGJU,TARGET-30-PATGJU-01A,Female,White,Not Hispanic or Latino,59,Censored,1219,Alive,1219,2010,2013,4s,single_copy,Hyperdiploid (DI>1),1.25,Favorable,Low,Neuroblastoma,Low,Primary tumor,1219,0,1219,0
